openPR Logo
Press release

Antidiabetics Market Eminent Players | AstraZeneca, Bayer Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Halozyme Therapeutics, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Novo Nordisk, Oramed Pharmaceuticals Inc., Pfizer, Sanof

11-07-2018 04:48 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Antidiabetics Market

Antidiabetics Market

Antidiabetics Market size is set to exceed USD 110 billion by 2024; according to a new research report by Global Market Insights.

Rising prevalence of diabetes due to unhealthy dietary habits including alcohol consumption, tobacco smoking coupled with physical inactivity will act as high impact rendering factor for industry growth. Furthermore, increasing number of baby boomers, susceptible to suffer from chronic conditions will stimulate antidiabetics business growth.

Favorable government policies such as paying part of final price of diabetes medication to reduce prevailing disease burden and rising awareness about early disease diagnosis and treatment will positively impact industry growth. Organizations such as International Diabetes Federation working towards advocating people about diabetes and its treatment available in the market should positively impact growth.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/504

Industry players are investing heavily in research and development to introduce superior treatment for diabetes in the market to gain significant market share as well as augment consumer base. Strong product pipeline indicates robust growth of antidiabetics market over the forecast timeframe. However, high price of insulin and other antidiabetic products will hamper anti-diabetics industry expansion to certain extent especially in low- and middle-income countries over the coming years.

Drug class product segment anticipated to reach over 43 billion by 2024 includes alpha glucosidase inhibitors, biguanides, sulphonylureas, GLP-I (Glucagon-like peptide 1), DPP-IV (Dipeptidyl peptidase-4), meglitinides, SGLT-II (gliflozin) and thiazolidinedione. Industry players, investing heavily in development of superior antidiabetic drugs will drive segment growth in future. Company named Valviotis is currently conducting preclinical testing for drug developed for increasing gut microbiome diversity, that would function as treatment of the target disease.

Pediatric segment by patient population will grow considerably with 11.4% CAGR during the forecast period. Growing prevalence of type 1 diabetes among children will drive pediatric segment by patient population over the forecast timeframe. While adult segment will be driven by lifestyle changes, unhealthy diet and growing obese population.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/504

Insulin syringe/pen segment is anticipated to witness 10.4% CAGR during the forecast period. Rising demand for self-injection devices, elevated accuracy in dosage delivery and growing prevalence of diabetes will drive insulin syringe/pen segment over the coming years. Cost-effectiveness of insulin pens as compared to insulin pumps should contribute towards segment growth.

U.S. market dominated the global industry with around 39% market share in 2017 and is estimated to show lucrative growth during the forecast period. Favorable government policies to reduce chronic disease burden in the country coupled with frequent product launches and high adoption rate will drive U.S. antidiabetics market during the forecast period.  

 
China market is anticipated to reach over 9.4 billion by 2024. Rising prevalence of diabetes and increasing geriatric population and will act as major driving factor for China antidiabetics market. Growing adoption of unhealthy diet, escalated consumption of alcohol and tobacco smoking along with physical inactivity will result in increasing number of diabetic patients, thereby fueling industry growth.

 
Some of the notable players operating in antidiabetics market are Eli Lilly, Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Merck, Boehringer Ingelheim, Oramed Pharmaceuticals, Takeda Pharmaceutical and Sanofi. Industry players are focusing on research and development to develop superior product to gain significant market share and increase their consumer base in especially developing countries that are estimated to witness robust growth during the forecast timeframe.
 

Antidiabetics Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Antidiabetics Market, by Product
o Insulin
o Rapid acting analog
o Long acting analog
o Premixed insulin
o Short acting analog
o Intermediate acting insulin
o Drug class
o Alpha glucosidase inhibitors
o Biguanides
o Sulphonylureas
o GLP-1 (Glucagon like peptide) agonists
o DPP-IV (Dipeptidyl Peptidase) inhibitors
o Meglitinides
o SGLT-II (Sodium Glucose Transport Proteins) inhibitors
o Thiazolidinedione

Antidiabetics Market, by Patient Population
o Pediatric
o Adult
o Geriatric

Antidiabetics Market, by Route of Administration
o Insulin syringe/ Insulin pen
o Insulin pump
o Intravenous infusion
o Oral
o Others

The above information is provided for the following regions and countries:

• North America
o U.S.
o Canada

• Europe
o Germany
o UK
o France
o Spain
o Italy
o Others

• Asia Pacific
o China
o Japan
o India
o Australia
o Others

• Latin America
o Brazil
o Mexico
o Others

• Middle East & Africa
o South Africa
o Saudi Arabia
o Others

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antidiabetics Market Eminent Players | AstraZeneca, Bayer Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Halozyme Therapeutics, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Novo Nordisk, Oramed Pharmaceuticals Inc., Pfizer, Sanof here

News-ID: 1355934 • Views: 651

More Releases from Global Market Insights, Inc.

Europe sodium silicate market is set to witness increasing demand over 2020-2024
Europe sodium silicate market is set to witness increasing demand over the forecast timeframe. In 2016, Europe accounted for more than 20% of the global sodium silicate market share. The region’s environmentally friendly regulations and increasing awareness would be increasing wastepaper recycling demand, stimulating industry growth during the forecast period. Owing to the integral nature of sodium silicate in a number of high-revenue application segments and the anticipated rise in
North America Thermal spray coating market to experience strong demand across ae …
Regionally, North America will emerge as a profitable revenue pocket for thermal spray coating market share in the coming years. High purchasing power among people in the region is supporting expansion in various sectors such as automobiles, aerospace, healthcare and construction. In 2016, North America thermal spray coating market size with respect to revenues was valued at over USD 2.3 billion due to the need to achieve cost optimization in
Increasing consumer inclination towards compact devices to bolster liquid crysta …
Shifting trends towards miniaturization of electronic components is poised to drive global liquid crystal polymer (LCP) market size, along with growing consumer demand for sleek and compact electronic devices. Liquid crystal polymers are high performance engineering plastics based on p-HPA (hydroxy phthalic acid) and related monomers. It has wide application outlook in consumer goods packaging owing to its superior mechanical & physical properties and processability. Liquid crystal polymers find wide range
Sodium sulfide market size is slated to top $665 mn by 2024, pulp & paper applic …
Sodium sulfide market from pulp & paper application is projected to garner robust CAGR of 6.5% through 2024, mainly attributed to demand growth of tissue and packaging papers in APAC, Europe and South America. It is worth mentioning that the product has become highly sought-after in processing of bamboo, wood, bagasse fibers to pulp and bleaching of the pulp that bolster the strength of paper. Get sample copy of this research

All 5 Releases


More Releases for Antidiabetics

US Antidiabetics Drug Market Outlook 2022 Report
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin
US Antidiabetics Drug Market Outlook 2022 Report Download
“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology (Prevalence of Type 1 and 2 Diabetes) in the US market along with the associated economic burden and productivity loss. “US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs
Antidiabetics Market Intelligence with Competitive Landscape 2023
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. The anti-diabetics market
Global Antidiabetics Drug Market Size - Industry Analysis And Forecast
Latest industry research report on: Global Antidiabetics Drug Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1270897 Global Antidiabetics Drug market competition by top manufacturers, with production, price, revenue
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin 2.2 Historical En Route towards Oral Diabetic Medication Treatments Available for Diabetes Mellitus 3.1 Non-Pharmacological Approaches for Diabetes Mellitus 3.2 Pharmacological Approaches for Diabetes Mellitus Cataloguing of Antidiabetic Agents 4.1
US To Dominate Global Antidiabetics Drug Market
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Download Report: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin